Chicken IgY Antibodies Provide Mucosal Barrier against SARS-CoV-2 Virus and Other Pathogens

Isr Med Assoc J. 2021 Apr;23(4):208-211.


This mini review includes two case descriptions. It introduces the use of chicken egg yolk antibody (IgY) solutions in the prevention and cure of viral and bacterial infections. Application for the protection against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), rotavirus, and influenza viruses, as well as for the eradication of Pseudomonas aeruginosa, caries, various enteric bacteria and other pathogens, and toxins have been developed. This approach is a fast, reliable, safe, and tested method for producing molecular shield and protection against emerging pathogens and epidemics. In the current pandemic situation caused by coronavirus disease-2019 (COVID-19), this method of passive immunization could be applied for rapid protection against modifiable agents. The specific IgY antibodies start to accumulate into egg yolks about 3 weeks after the immunization of the chicken. The product can be collected safely, as the antigen is not found in the eggs. This method for microbial safety uses natural means and commonly used food substances, which have been tested and could be produced for both blocking epidemics and applying personalized medicine.

Publication types

  • Review

MeSH terms

  • Animals
  • Antibodies / therapeutic use*
  • Bacterial Infections / prevention & control
  • COVID-19 / prevention & control*
  • Chickens
  • Egg Yolk / immunology*
  • Humans
  • Immunity, Mucosal / immunology
  • Immunization, Passive / methods*
  • Immunoglobulins / immunology*
  • Infant, Newborn
  • Virus Diseases / prevention & control


  • Antibodies
  • IgY
  • Immunoglobulins